Molecular immunotoxicology testing in vitro

C Meredith1, K Miller

  • 1Immunotoxicology Department, BIBRA Toxicology International, Woodmansterne Road, Carshalton, Surrey SM5 4DS, UK.

Insights

Researchers developed reproducible dot-blot assays to measure cytokine mRNA expression, aiding the development of in vitro immunotoxicology screening for drugs and chemicals.

Area of Science:

  • Immunology
  • Toxicology
  • Molecular Biology

Background:

  • Cytokine expression analysis is crucial for developing in vitro immunotoxicological screening assays.
  • Reverse transcription-polymerase chain reaction (RT-PCR) is sensitive but lacks reproducibility, while dot-blot analysis offers a reproducible alternative.

Purpose of the Study:

  • To establish reproducible methods for analyzing cytokine mRNA expression.
  • To propose simple tests for predicting the immunomodulatory potential of new compounds.

Main Methods:

  • Utilized dot-blot analysis for reproducible cytokine mRNA expression quantification.
  • Investigated the effects of immunostimulatory and immunosuppressive drugs on cytokine mRNA levels in murine cell cultures.
  • Applied techniques to human peripheral blood mononuclear cells for assessing allergenic potential.

Main Results:

  • Macrophage IL-1 mRNA was induced by Biostim (10 pg/ml).
  • Cyclosporin A (1 ng/ml) inhibited lymphocyte-derived IL-2 mRNA expression.
  • Azathioprine and tributyltin oxide partially inhibited IL-2 and/or IL-2 receptor mRNA in mixed lymphocyte cultures.

Conclusions:

  • Dot-blot analysis provides a reproducible method for cytokine mRNA expression analysis.
  • Proposed assays can predict the immunomodulatory potential of compounds.
  • Techniques are applicable to human cells for evaluating drug and chemical allergenicity.

Related Concept Videos

In vitro Mutagenesis01:16

In vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.